MX2016016746A - Composiciones de vacuna con adyuvante dual, preparacion y usos. - Google Patents

Composiciones de vacuna con adyuvante dual, preparacion y usos.

Info

Publication number
MX2016016746A
MX2016016746A MX2016016746A MX2016016746A MX2016016746A MX 2016016746 A MX2016016746 A MX 2016016746A MX 2016016746 A MX2016016746 A MX 2016016746A MX 2016016746 A MX2016016746 A MX 2016016746A MX 2016016746 A MX2016016746 A MX 2016016746A
Authority
MX
Mexico
Prior art keywords
preparation
vaccine compositions
adjuvant vaccine
dual adjuvant
dual
Prior art date
Application number
MX2016016746A
Other languages
English (en)
Other versions
MX382088B (es
Inventor
H Ruehling Roger
Ford Brianna
Original Assignee
Biomune Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomune Company filed Critical Biomune Company
Publication of MX2016016746A publication Critical patent/MX2016016746A/es
Publication of MX382088B publication Critical patent/MX382088B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a vacunas que comprenden una cantidad eficaz de al menos un antígeno en una emulsión de agua en aceite en agua (WOW) y un adyuvante adicional, y a los métodos de preparación y usos de las mismas.
MX2016016746A 2014-06-16 2015-06-15 Composiciones de vacuna con adyuvante dual, preparación y usos. MX382088B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/305,329 US20150359880A1 (en) 2014-06-16 2014-06-16 Dual adjuvant vaccine compositions, preparation and uses
PCT/US2015/035742 WO2015195504A1 (en) 2014-06-16 2015-06-15 Dual adjuvant vaccine compositions, preparation and uses

Publications (2)

Publication Number Publication Date
MX2016016746A true MX2016016746A (es) 2017-07-11
MX382088B MX382088B (es) 2025-03-11

Family

ID=53499085

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016016746A MX382088B (es) 2014-06-16 2015-06-15 Composiciones de vacuna con adyuvante dual, preparación y usos.

Country Status (9)

Country Link
US (2) US20150359880A1 (es)
EP (1) EP3154575A1 (es)
JP (1) JP2017518338A (es)
CN (1) CN107073097A (es)
MX (1) MX382088B (es)
PE (1) PE20170243A1 (es)
RU (1) RU2729646C2 (es)
WO (1) WO2015195504A1 (es)
ZA (1) ZA201608487B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8680390B2 (en) 2009-10-16 2014-03-25 Kesumo Llc Foot-operated controller
US9076419B2 (en) 2012-03-14 2015-07-07 Bebop Sensors, Inc. Multi-touch pad controller
US10362989B2 (en) 2014-06-09 2019-07-30 Bebop Sensors, Inc. Sensor system integrated with a glove
US9827996B2 (en) 2015-06-25 2017-11-28 Bebop Sensors, Inc. Sensor systems integrated with steering wheels
JP2019001770A (ja) * 2017-06-15 2019-01-10 エス・ピー・ジーテクノ株式会社 乳化型ワクチン製剤とその生成用デバイス
US10884496B2 (en) 2018-07-05 2021-01-05 Bebop Sensors, Inc. One-size-fits-all data glove
CN109663125A (zh) * 2019-01-30 2019-04-23 山东省农业科学院畜牧兽医研究所 一种鸡肠炎沙门氏菌灭活疫苗及其应用
US11480481B2 (en) 2019-03-13 2022-10-25 Bebop Sensors, Inc. Alignment mechanisms sensor systems employing piezoresistive materials
CN115253736A (zh) * 2022-07-21 2022-11-01 苏州逻晟生物医药有限公司 一种新的抗原乳化方法
WO2024107677A1 (en) * 2022-11-14 2024-05-23 Elanco Us Inc. Salmonella vaccine compositions and methods thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069313A (en) * 1974-11-19 1978-01-17 Merck & Co., Inc. Water-in-oil adjuvant composition
FR2649012B1 (fr) * 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
US5622649A (en) 1991-06-27 1997-04-22 Emory University Multiple emulsions and methods of preparation
EP0640348A1 (en) 1993-07-26 1995-03-01 Akzo Nobel N.V. Oil-based and water-based adjuvant mixture
US5817320A (en) * 1994-06-20 1998-10-06 The United States Of America As Represented By The Secretary Of The Agriculture In ovo immunization of avian embryos with oil-emulsion vaccines
JPH11269093A (ja) * 1998-01-22 1999-10-05 Shionogi & Co Ltd 油性アジュバントワクチン製剤
US20020051748A1 (en) * 1998-12-22 2002-05-02 William C. Snow Stabilized water-in-oil-in-water antigen delivery system
JP2001131087A (ja) * 1999-11-05 2001-05-15 Chemo Sero Therapeut Res Inst オイルアジュバントワクチン
JP2002080396A (ja) * 2000-09-06 2002-03-19 Nippon Inst For Biological Science 鶏用ワクチン製剤
WO2002038175A1 (en) 2000-11-07 2002-05-16 Immunovaccine Technologies Inc. Vaccines with enhanced immune response and methods for their preparation
CA2528007C (en) * 2003-06-02 2012-03-27 Chiron Corporation Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen
US7691368B2 (en) * 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
PL1951299T3 (pl) * 2005-11-04 2012-07-31 Novartis Ag Szczepionki przeciw grypie zawierające kombinacje adiuwantów cząsteczkowych i czynników wzmacniających immunogenność
UA100370C2 (uk) * 2006-12-11 2012-12-25 Мериал Лимитед Спосіб вакцинації птахів проти salmonella
JP2009215226A (ja) * 2008-03-11 2009-09-24 Chemo Sero Therapeut Res Inst 動物用不活化サルモネラ３価ワクチンおよびその調製方法
EP2328614A1 (en) * 2008-08-06 2011-06-08 Novartis AG Microparticles for use in immunogenic compositions
US20110052633A1 (en) 2009-09-02 2011-03-03 National Health Research Institutes Multi-phase emulsions based on amphiphilic block copolymers
WO2012092226A1 (en) 2010-12-27 2012-07-05 Biomune Company Veterinary vaccine composition against infections caused by salmonella
CN103223164B (zh) * 2013-04-15 2014-08-20 华南农业大学 一种水包油包水型佐剂疫苗及其制备方法

Also Published As

Publication number Publication date
WO2015195504A1 (en) 2015-12-23
EP3154575A1 (en) 2017-04-19
PE20170243A1 (es) 2017-04-19
CN107073097A (zh) 2017-08-18
MX382088B (es) 2025-03-11
US20170196972A1 (en) 2017-07-13
BR112016029513A2 (pt) 2017-08-22
ZA201608487B (en) 2018-05-30
RU2017101091A (ru) 2018-07-16
JP2017518338A (ja) 2017-07-06
RU2017101091A3 (es) 2018-12-18
US20150359880A1 (en) 2015-12-17
US10772954B2 (en) 2020-09-15
RU2729646C2 (ru) 2020-08-11

Similar Documents

Publication Publication Date Title
MX2016016746A (es) Composiciones de vacuna con adyuvante dual, preparacion y usos.
MX2022002106A (es) Formulaciones de vacuna de vial unico.
MA46766A (fr) Vaccin antigrippal
MX2018002728A (es) Composiciones de vacuna que tienen estabilidad e inmunogenicidad mejoradas.
BR112013022397A2 (pt) vacinas combinadas com doses menores de antígeno e/ou adjuvante
PL3639849T3 (pl) Szczepionka na bazie atenuowanego wirusa afrykańskiego pomoru świń
CL2017001961A1 (es) Vacuna bivalente contra el virus de gripe porcina
AR102547A1 (es) Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso
DK3603619T3 (da) Vaccineadjuvansformulering
MX2015016627A (es) Vacuna para la malaria.
MX2020004367A (es) Vacunas contra el zika, composiciones inmunogenicas y metodos que las utilizan.
CL2015001111A1 (es) Composición coadyuvante que comprende un hidrato de carbono unido al quitosano formando una base de schiff; formulación de vacuna que la comprende; método de elaboración; y uso de la vacuna.
MX2015012833A (es) Composiciones antibioticas de ceftolozano.
MX2023012390A (es) Vacunacion con particulas de replicon y adyuvante oleoso.
BR112017003462A2 (pt) coronavírus bovino atenuado, vacina, e, método de vacinação de um bovino.
EP2955192A4 (en) ANTI-MYCOPLASMA SPP. SUBUNIT VACCINE
UY36394A (es) Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso.
BR112019003992A2 (pt) vacina contra neisseria meningitidis
UA116697C2 (uk) Композиція для запобігання зараженню видами роду mycoplasma
BR112016022463A2 (pt) método para induzir uma resposta imune em um indivíduo, primeira e segunda composições imunogênicas, e, uso de uma primeira composição imunogênica e de uma segunda composição imunogênica
MX2016000235A (es) Metodos y composiciones para vacunas del virus del dengue.
CL2018000513A1 (es) Vacunas de pestivirus para temblores congénitos
ES2503516R1 (es) Complejo inmunogénico para vacunación y método de obtención
MX388527B (es) Composiciones adyuvantes y metodos relacionados.
CL2015001618A1 (es) Adyuvante de vacunación, preparación y vacunas que lo contienen